Inceptiv Closed-Loop Spinal Cord Stimulator

Inceptiv is an FDA-approved spinal cord stimulator for managing chronic
pain. Utilizing advanced closed-loop technology, it monitors biological
signals 50x/sec, automatically adjusting stimulation to block pain
signals before reaching the brain. Built for comfort, Inceptiv is the
smallest SCS available and offers unparalleled MRI access.

Viz HCM™

Viz HCM uses its FDA-cleared AI algorithm to analyze ECGs across health
systems 24/7 and identify and flag suspected hypertrophic
cardiomyopathy, a leading cause of sudden cardiac death in people under
age 35. Viz HCM’s mobile app is used to view patients’ chart/images,
discuss/coordinate next steps, and ensure they receive correct care
quickly.

Zio® monitor

Zio monitor is a prescription-only ECG monitor that continuously records
your heart’s activity for up to 14 days. It’s 23% thinner, 62% lighter,
and 72% smaller than the previous generation, making it the lightest
Long Term Continuous Monitor in the industry, the size and shape of an
adhesive bandage.

DeepArrest

DeepArrest is a cutting-edge AI-powered system engineered to predict
cardiac arrest up to six hours in advance, offering 95% sensitivity and
92% specificity. This marks a significant improvement over the 60-90
minutes with traditional detection. By analyzing six vital signs, it
enables timely, life-saving interventions across diverse care settings.

CellBio™ a2000 for Cancer Screening

CellBio a2000 technology is designed to ease out the cancer screening
and monitoring by isolating and recognizing the circulating tumor cells
in the blood. The open platform system not only provide new ways of
diagnosis but also aid in developing precision medicine to reduce the
risk of treatment.

SCINTIX® biology-guided radiotherapy

SCINTIX therapy is designed to treat all stages of cancer, providing a
new treatment for metastatic disease. It’s the first therapy to use
signals produced by the cancer itself to autonomously guide treatment,
even for tumors that are moving. SCINTIX expands radiotherapy from
single-tumor to multiple-tumors and reduces radiation to healthy tissue.

HrC™ Test

The HrC Test is a blood test that assesses the risk of cancer presence
or absence. It can detect all types of cancer in a single test with 93%
sensitivity, and can detect it before a tumor has formed. It is also a
prognostic test that can rule out the risk of cancer for the next 12
months. We can make cancer an early-stage, treatable disease.

PathoAiD®-Thyroid Dx

PathoAiD®-Thyroid Dx aims to address the significant issue of diagnostic
uncertainties which leads to thyroid cancer misdiagnosis, causing both
untreated cases and unnecessary surgeries. Our AI-driven product
uniquely interprets core needle biopsy images, enhancing diagnostic
accuracy and reducing financial burdens for patients.

A+ Clinical Intelligent Navigator

Chi Mei Medical Center is the pioneer in Asia’s AI healthcare with the
A+ Clinical Intelligent Navigator (HIS Copilot). This GAI system
enhances ward rounds, consolidates data, reduces prep time, and improves
safety. Launched in 2023, it serves 50,000+ monthly users across
hospital levels, transforming healthcare with patient-centered
innovation.

AQBioSim

AQBioSim is a suite of AI-powered tools that significantly reduce the
time, cost & risk of drug discovery R&D for challenging medical
conditions (e.g., Alzheimer’s, cancer) by identifying/designing
promising drug molecules, simulating their behaviors & properties,
screening for efficacy, toxicity & other criteria, and predicting
clinical success.

Ready for Nomination Season?

Complete the form below to download the 2027 Nomination Guide.

A Founders Guide to Modern Innovation
The Future of the Grid – Panel Discussion 2024 Edison Awards
Edison Award-Winning Brain Technology Featured in U.S. News & World Report